Annual Total Expenses
$69.90 M
+$295.50 K+0.42%
December 31, 2023
Summary
- As of February 7, 2025, IPHA annual total expenses is $69.90 million, with the most recent change of +$295.50 thousand (+0.42%) on December 31, 2023.
- During the last 3 years, IPHA annual total expenses has risen by +$7.01 million (+11.14%).
- IPHA annual total expenses is now -20.80% below its all-time high of $88.26 million, reached on December 31, 2018.
Performance
IPHA Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
N/A
June 30, 2024
Summary
- IPHA quarterly total expenses is not available.
Performance
IPHA Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
IPHA Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +0.4% | - |
| 3 y3 years | +11.1% | - |
| 5 y5 years | -20.8% | - |
IPHA Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -1.4% | +0.4% | ||
| 5 y | 5-year | -6.8% | +11.1% | ||
| alltime | all time | -20.8% | +534.1% |
Innate Pharma SA Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $69.90 M(+0.4%) | - |
| Dec 2022 | $69.61 M(-1.8%) | - |
| Dec 2021 | $70.92 M(+12.7%) | - |
| Apr 2021 | - | $209.70 M(+6.0%) |
| Jan 2021 | - | $197.77 M(-5.9%) |
| Dec 2020 | $62.90 M(-16.2%) | - |
| Oct 2020 | - | $210.22 M(-7.3%) |
| Jul 2020 | - | $226.70 M(+4.9%) |
| Apr 2020 | - | $216.09 M(+14.0%) |
| Jan 2020 | - | $189.60 M(-9.7%) |
| Dec 2019 | $75.05 M(-15.0%) | - |
| Oct 2019 | - | $209.97 M(-4.1%) |
| Jul 2019 | - | $218.99 M(+6.2%) |
| Apr 2019 | - | $206.16 M(+8.6%) |
| Jan 2019 | - | $189.87 M |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $88.26 M(+7.3%) | - |
| Oct 2018 | - | $208.55 M(-9.2%) |
| Jul 2018 | - | $229.59 M |
| Dec 2017 | $82.23 M(+52.9%) | - |
| Dec 2016 | $53.78 M(+69.0%) | - |
| Dec 2015 | $31.83 M(+14.6%) | - |
| Dec 2014 | $27.76 M(+37.1%) | - |
| Dec 2013 | $20.24 M(+14.5%) | - |
| Dec 2012 | $17.67 M(-15.5%) | - |
| Dec 2011 | $20.92 M(-12.4%) | - |
| Dec 2010 | $23.87 M(-26.4%) | - |
| Dec 2009 | $32.42 M(-14.8%) | - |
| Dec 2008 | $38.07 M(+18.8%) | - |
| Dec 2007 | $32.05 M(+62.3%) | - |
| Dec 2006 | $19.75 M(+79.1%) | - |
| Dec 2005 | $11.02 M | - |
FAQ
- What is Innate Pharma SA annual total expenses?
- What is the all time high annual total expenses for Innate Pharma SA?
- What is Innate Pharma SA annual total expenses year-on-year change?
- What is the all time high quarterly total expenses for Innate Pharma SA?
What is Innate Pharma SA annual total expenses?
The current annual total expenses of IPHA is $69.90 M
What is the all time high annual total expenses for Innate Pharma SA?
Innate Pharma SA all-time high annual total expenses is $88.26 M
What is Innate Pharma SA annual total expenses year-on-year change?
Over the past year, IPHA annual total expenses has changed by +$295.50 K (+0.42%)
What is the all time high quarterly total expenses for Innate Pharma SA?
Innate Pharma SA all-time high quarterly total expenses is $229.59 M